These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Biosafety and biosecurity in the medical laboratory. Update and trends]. Ionescu G, Neguţ M, Combiescu AA. Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721 [Abstract] [Full Text] [Related]
23. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E, Landini MP, Sekeyova Z, Dumler JS, Bădescu D, Busquets N, Calistri A, Parolin C, Palù G, Christova I, Maurin M, La Scola B, Raoult D. Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1247-58. PubMed ID: 27234593 [Abstract] [Full Text] [Related]
24. Biosafety Level 4 Laboratory User Training Program, China. Xia H, Huang Y, Ma H, Liu B, Xie W, Song D, Yuan Z. Emerg Infect Dis; 2019 May; 25(5):. PubMed ID: 31002302 [Abstract] [Full Text] [Related]
25. Establishing a biosafety plan for a flow cytometry shared resource laboratory. Back JB, Martinez L, Nettenstrom L, Sheerar D, Thornton S. Cytometry A; 2022 May; 101(5):380-386. PubMed ID: 35037390 [Abstract] [Full Text] [Related]
26. Biosafety breaches. Accidents spur a closer look at risks at biodefense labs. Kaiser J. Science; 2007 Sep 28; 317(5846):1852-4. PubMed ID: 17901309 [No Abstract] [Full Text] [Related]
27. Biosafety in the clinical mycobacteriology laboratory. Richmond JY, Knudsen RC, Good RC. Clin Lab Med; 1996 Sep 28; 16(3):527-50. PubMed ID: 8866179 [Abstract] [Full Text] [Related]
28. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts. van Soolingen D, Wisselink HJ, Lumb R, Anthony R, van der Zanden A, Gilpin C. Int J Tuberc Lung Dis; 2014 Aug 28; 18(8):885-9. PubMed ID: 25199000 [Abstract] [Full Text] [Related]
29. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent. Kaufer AM, Theis T, Lau KA, Gray JL, Rawlinson WD. Pathology; 2020 Dec 28; 52(7):790-795. PubMed ID: 33070960 [Abstract] [Full Text] [Related]
30. Communication and computing technology in biocontainment laboratories using the NEIDL as a model. McCall J, Hardcastle K. Pathog Dis; 2014 Jul 28; 71(2):96-101. PubMed ID: 24535887 [Abstract] [Full Text] [Related]
31. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting. Mourya DT, Yadav PD, Majumdar TD, Chauhan DS, Katoch VM. Indian J Med Res; 2014 Aug 28; 140(2):171-83. PubMed ID: 25297350 [Abstract] [Full Text] [Related]
32. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks. Peng H, Bilal M, Iqbal HMN. Int J Environ Res Public Health; 2018 Nov 29; 15(12):. PubMed ID: 30501091 [Abstract] [Full Text] [Related]
33. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues. Mourya DT, Yadav PD, Khare A, Khan AH. Indian J Med Res; 2017 Oct 29; 146(4):459-467. PubMed ID: 29434059 [Abstract] [Full Text] [Related]
34. [Research on the framework of biosafety standards for pathogenic microbial laboratories]. Li J, Chen Z, Li SS, Lu B, Zhao SQ, Wang R, Cao GQ, Wang W, Ma CT, Hou XX, Wang YH, Zhao CH, Wu GZ. Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb 10; 45(2):294-299. PubMed ID: 38413071 [Abstract] [Full Text] [Related]
35. Assessment of biosafety precautions in Khartoum state diagnostic laboratories, Sudan. Elduma AH. Pan Afr Med J; 2012 Feb 10; 11():19. PubMed ID: 22514753 [Abstract] [Full Text] [Related]
36. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring. Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Keita MS, Rayfield MA, Peruski LF, Pierson A. Health Secur; 2022 Feb 10; 20(6):488-496. PubMed ID: 36383124 [Abstract] [Full Text] [Related]
37. Biosafety during a pandemic: shared resource laboratories rise to the challenge. Aspland AM, Douagi I, Filby A, Jellison ER, Martinez L, Shinko D, Smith AL, Tang VA, Thornton S. Cytometry A; 2021 Jan 10; 99(1):68-80. PubMed ID: 33289290 [Abstract] [Full Text] [Related]
38. [Current biosafety in clinical laboratories in Japan: report of questionnaires' data obtained from clinical laboratory personnel in Japan]. Goto M, Yamashita T, Misawa S, Komori T, Okuzumi K, Takahashi T. Kansenshogaku Zasshi; 2007 Jan 10; 81(1):39-44. PubMed ID: 17338315 [Abstract] [Full Text] [Related]
39. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017. Appelt S, Jacob D, Rohleder AM, Bråve A, Szekely Björndal Å, Di Caro A, Grunow R, Joint Action EMERGE laboratory networkThe EMERGE partners are acknowledged at the end of the article.. Euro Surveill; 2020 Sep 10; 25(36):. PubMed ID: 32914748 [Abstract] [Full Text] [Related]
40. Results of a 2020 Survey on Reporting Requirements and Practices for Biocontainment Laboratory Accidents. Manheim DB. Health Secur; 2021 Nov 10; 19(6):642-651. PubMed ID: 34818064 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]